Life Sciences Blog
Recent Posts
- Blog: Biologics BlogOpposition to Rehearing Filed in Major Federal Circuit Case Narrowing Hatch-Waxman VenuePosted on January 10, 2021 by Last week, Mylan filed a brief in opposition to Valeant’s petition for rehearing en banc in Valeant Pharms. N. Am. LLC v. Mylan Pharms. Inc., No. 2019-2402. In November, a Federal Circuit panel held that venue in Hatch-Waxman cases brought under 35 U.S.C. § 271(e)(2)(A) is proper “only in districts where actions related to the submission of [...]